Hawaii Pacific Neuroscience Clinical Research Center (CRC) proven model, and combined years of experience affords us the ability to provide Hawaii patients with groundbreaking new neuroscience treatment options.
The Hawaii Pacific Neuroscience Clinical Research Center (CRC) is a proven model with decades of combined years of experience that affords us the ability to provide our local patients with ground-breaking neuroscience treatment options.
Our staff includes 8 full-time Investigators, 5 dedicated full-time research staff and over 10 administrative support staff with Regulatory, Quality Assurance, Business Development, Recruitment Specialists roles included. Our CRC has an active database of over 20,000 subjects and growing. Principal Investigator, Kore Liow, MD, is an NIH trained research neurologist who has served as the PI for over 20 years for more than 100 phase I through IV neuroscience clinical trials funded by NIH, CDC, and the industry. He also has published over 40 peer-reviewed scientific neuroscience articles.
According to NIH NIMHD (National Institute on Minority Health & Health Disparities), one of America’s greatest challenges is reducing the profound disparity in health status of its racial and ethnic minority, rural, low-income, and other underserved populations. Hawaii is one of the most diverse state and home to several NIMHD designated US health disparity populations including:
Native Hawaiians and other Pacific Islanders including Socioeconomically disadvantaged populations in Underserved Rural areas (94% of Total Land area housing 8% of population in Hawaii)
The Hawaii Pacific Neuroscience CRC’s goal is to contribute to NIH NIMHD’s goals of “enhancing the scientific knowledge base and designing interventions to improve health outcomes to reduce and ultimately lead to the elimination of health disparities’ by ensuring that clinical trials include racial and ethnic diversity including minority groups that constitute substantial and growing proportions of the US population. For example, according to the 2010 US census, 6% of those identified themselves as Asian. It is important for clinical trial populations to reflect the targeted patient population. Our Clinical Research Center strives to represent the trial populations that are an important facet of clinical trial designs and positively contribute to the scientifically rigorous evaluation of therapies being investigated to ensure that the safety and efficacy profile of a treatment is accurate.
Hawaii Pacific Neuroscience is committed to improving health care access, reducing health disparities especially for minorities and those underserved in our state and are proud to be working with organizations to serve these populations. Further information, contact Principal Investigator Kore Kai Liow, MD, kliow@HawaiiNeuroscience.com
Dr. Kore Kai Liow is a board-certified neurologist with over 20 years of clinical research experience. He has personally served as the PI for over 100 Phase I-IV neuroscience clinical trials. His research has been published in over 40 peer-reviewed publications and has received the “Honolulu Top Doctors” award in 2015, 2016 and 2017.
***We Promise, no spam!